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Abstract
Background: Severe anaemia is a common, frequently fatal, condition in African children admitted to hospital, but its long
term outcome is unknown. Early reports that survivors may be at risk of additional late morbidity and mortality may have
significant implications for child survival in Africa. We assessed the short and long term outcome of severe anaemia in
Malawian children and identified potential risk factors for death and further severe anaemia.
Methodology and Findings: For 18 months, we followed up children (6–60 months old) presenting to hospital with severe
anaemia (haemoglobin #5g/dl) and their hospital and community controls with the aim to compare all cause mortality and
severe anaemia recurrence rates between the groups, and to identify risk factors for these adverse outcomes. A total of 377
cases, 377 hospital controls and 380 community controls were recruited. Among cases, the in-hospital mortality was 6.4%
and post-discharge all cause mortality was 12.6%, which was significantly greater than in hospital controls (2.9%) or
community controls (1.4%) (Log rank test, p,0.001). The incidence of recurrence of severe anaemia among the cases was
0.102 per child-year (95% Confidence Interval 0.075–0.138), and was significantly higher than the 0.007 per child-year (95%
CI 0.003–0.015) in the combined controls (p,0.0001). HIV was the most important risk factor both for post-discharge
mortality (Hazard Ratio 10.5, 95% CI 4.0–27.2) and for recurrence of severe anaemia (HR 5.6, 95% CI 1.6–20.1).
Conclusions: Severe anaemia carries a high ‘hidden’ morbidity and mortality occurring in the months after initial diagnosis
and treatment. Because severe anaemia is very common, this is likely to contribute importantly to overall under-five
mortality. If not adequately addressed, severe anaemia may be an obstacle to achievement of the Millennium development
goal No.4 on child survival. Strategies to diagnose and properly treat HIV infected children early most likely will reduce the
high post-discharge mortality in severe anaemia.
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Introduction
Severe anaemia is a common condition causing significant
morbidity and mortality in children in Africa. Of children
admitted to hospital, 12–29% have severe anaemia requiring a
blood transfusion and the in-hospital mortality is commonly very
high, ranging between 4% and 10% [1,2,3]. Although the
condition may be caused by various aetiological factors, most
important being nutritional deficiencies and infections such as
HIV and malaria [2,4,5], these factors usually occur simulta-
neously and are complexly related. In these parts of the world,
hospitals are commonly challenged to manage severely anaemic
children with poor or absent diagnostic facilities.
Investigators in Kenya reported unexpectedly high post-
discharge mortality and recurrent severe anaemia rates in children
within two months of a severe anaemia episode [2]. There has
been no subsequent attempt to confirm or investigate these
findings. An excess risk of death in this large group could
contribute an important, and potentially correctable, component
to the high mortality rate among young children in Africa.
In this study our first aim was to compare rates of survival and
of recurrence of severe anaemia over 18 months between children
admitted to hospital with severe anaemia, children admitted to
hospital for other reasons and healthy children in the local
community. Secondly we aimed to investigate risk factors for
recurrent severe anaemia and all cause mortality during an 18-
month follow-up period.
Methods
This study was the longitudinal part of a case-control study
investigating the aetiological factors for severe anaemia in children
[6]. We followed up three groups of children namely: (1) those who
were admitted to hospital for treatment of severe anaemia (cases),
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controls) and (3) those from the community of each case
(community controls). It was conducted in southern Malawi at
Queen Elizabeth Central hospital in Blantyre and Chikwawa
District hospital. In Blantyre (urban site) malaria is seasonal, while
in Chikwawa (rural site) malaria transmission is intense throughout
the year.
Children were recruited from July 2002 to July 2004 and
followed up until February 2006 from the hospital’s Paediatric
Accident and Emergency Unit (Blantyre) or Under-fives Clinic
(Chikwawa). Each of these is a facility available to the public
without charge, functioning in daylight hours for six days each
week. Severely anaemic children (cases) were recruited if they had a
blood haemoglobin concentration ([Hb]) of less than 5.0 g/dl,
were aged 6–60 months and had not received a blood transfusion
during the preceding four weeks. A child was not enrolled if the
anaemia was known to be due to malignancy or trauma. For each
case a Hospital Control (HC) was recruited the following day on
presentation to the same out-patient department for a condition
other than severe anaemia, and when the index case was
discharged from hospital a Community Control (CC) was recruited
from among apparently healthy children in the community. The
guardian of the index case assisted in identifying the nearest child
not part of the immediate family residing within 100–1000metres
of the home of the index case. HC and CC had to be aged between
6 and 60 months, and not severely anaemic. Written informed
consent was obtained from the guardians of the children and the
study was approved by the ethics committees of the University of
Malawi and the Liverpool School of Tropical Medicine, UK.
Clinical procedures
The process of recruitment included a detailed medical history
and physical examination. Samples of venous blood, urine and
stool were collected. Children requiring hospitalisation (all cases
and a minority of HCs) received 24 hour care in a specialised
research ward while in hospital. An array of laboratory tests to
determine the aetiology of the clinical condition (described below)
were performed [6]. Cases received an urgent blood transfusion
(20mls whole blood per kilogram body weight). Severe malaria was
treated with parenteral quinine until the child was able to take oral
medication, then sulfadoxine-pyrimethamine was given according
to national policy at that time [7]. Antibiotics were given only
when clinically indicated. All correctable conditions were treated
according to a standard protocol before children were discharged
from hospital.
Participant follow-up
All three study groups (cases, HC and CC) were actively followed
up at 1, 3, 6, 12 and 18 months from date of discharge. Guardians
were additionally asked to return with the child to a study clinic
whenever the child was sick. During each follow-up visit, a
standard clinical form was completed and, if necessary, the child
was treated by the attending clinician. At the time of this study,
anti-retroviral therapy (ART) was not available to children in
Malawi. Deaths and severe anaemia episodes were recorded, and
if they occurred outside the study clinics, they were investigated as
completely as possible using the patient’s ‘Health Passport’ book,
hospital records and home interviews with parents or guardians.
Deaths occurring during the initial hospitalisation period were
recorded as in-hospital mortality. Deaths occurring after discharge
but during the study follow-up period were recorded as post-
discharge all cause mortality and information surrounding the
death was collected using a verbal autopsy [8].
Laboratory methods
All laboratory assays were done in all study groups, unless
otherwise stated and were blinded to patient study group where
possible. Haemoglobin concentration was measured on site using
the HemoCue B-Haemoglobin analyser (HemoCue, A ¨ngelholm,
Sweden) and subsequently by Coulter counter analyser (Beckman
Coulter, Durban, South Africa). Ferritin was measured using the
electrochemiluminescence immunoassay (Modular Analytics
E170, Roche Diagnostics, Switzerland. Soluble transferrin recep-
tor (sTfR) levels were measured using ELISA (Ramco Laborato-
ries, TX, USA). Iron deficiency was defined as a sTfR/log ferritin
index of 5.6 or more [9,10]. Malaria was defined as the presence of
Plasmodium falciparum asexual parasites in the blood. Stool samples
were examined for helminth infection by Kato-Katz and
Polymerase Chain Reaction (PCR) [11]. Urine specimens were
examined for Schistosoma haematobium using a semiquantative
concentration method [12]. Bacterial cultures were carried out
only on cases and HC according to a standard method using an
automated BacT/Alert system (BioMe ´rieux Industry, MO, USA)
and cultured for 7 and 56 days for routine pathogens and
mycobacteria respectively. Mixed growth or growth of Micrococci,
Bacillus species or coagulase-negative staphylococci were consid-
ered contaminants. HIV testing was performed according to
WHO guidelines using two rapid tests (Determine, Abbott-
Laboratories, Japan; Unigold, Trinity-Biotech, Ireland). Discor-
dant results and reactive results in children less than 18 months
were resolved by PCR [13]. For genetic analysis, DNA was
extracted using a Nucleon extraction kit (Amersham biosciences,
UK) and tested by Cytronomics and arms-PCR for a predefined
set of polymorphisms including glucose-6-phosphate dehydroge-
nase deficiency (G6PD, variant A- 202/376) [14], sickle cell
disease (homozygosity for hemoglobin S) and single nucleotide
polymorphism in the promoter region of the genes encoding
interleukin-10 (IL10) (–1117, 23585, and +4949) [15] and tumor
necrosis factor (TNF)( 2238, 2308, and 21031) [16] .
Statistical analysis
Data were analyzed using SPSS for Windows version 12 and
STATA version 9. To compare the characteristics of the three
groups of children, discrete data were analyzed by the Fisher exact
test and continuous data by independent samples Student’s t-tests.
Survival times were recorded as the duration of follow-up from the
date of recruitment or the date of discharge (if hospitalised at time
of recruitment) until the date of a severe anaemia episode or post-
discharge mortality. Severe anaemia was defined as [Hb] less than
5g/dl during the follow-up period and at least four weeks after a
previous severe anaemia episode. Kaplan-Meier curves were
plotted for the three groups of children and compared using the
Log-rank test.
We investigated the associations between risk factors deter-
mined at recruitment and post-discharge all cause mortality during
the 18 month follow-up period among cases. It was not possible to
perform a similar analysis for HC and CC owing to the few deaths
observed in these study groups. Among cases, we examined the
association with all cause mortality of the following risk factors:
residing in an urban/rural area, sex (male/female), age (in
months), education of mothers of study participants (none/some),
employment of parents (unemployed/employed), number of
siblings (.2 siblings/#2 siblings), history of previous blood
transfusion (yes/no), history of jaundice (yes/no), blood in urine
or stool (present/absent), wasting (,22 Z-score weight-for-
height/$22 Z-score weight-for-height), stunting (,22 Z-score
height-for-age/$22 Z-score height-for-age), undernutrition
(,22 Z-score weight-for-age/$22 Z-score weight-for-age),
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L), iron deficiency ($5.6 sTfR/Log ferritin/,5.6 sTfR/Log
ferritin), hookworm (present/absent), malaria (0/any asexual
parasites/mL blood), HIV infection (positive/negative), bacterae-
mia (present/absent), non-typhoidal salmonella bacteraemia
(present/absent).
Cox proportional hazards models were used to examine the
association between risk factors mentioned above and all cause
mortality through the 18 months post-discharge follow-up period.
Initially, each covariate (risk factor) was entered into a separate
univariate model with time to post-discharge death entered as the
dependent variable. All covariates with p#0.10 in the univariate
models and important confounders (age, sex, residency and HIV
status) were entered into a multivariable model. We also compared
the proportion of children with HIV infection by study group
using chi-squared test and determined the respective risk ratios.
We performed a similar analysis (as that for all cause mortality)
to assess risk factors for the development of first recurrence of
severe anaemia during the follow-up period among cases. This
analysis was not possible for HC and CC owing to the few
recurrences of severe anaemia in these study groups.
Results
A total of 381 cases, 377 HC children and 380 CC children
were recruited; 4 cases had to be excluded from the statistical
analysis because outcome information was missing, reducing this
cohort to 377 children. Of all children, 53.4% (606/1134) were
from the urban site (Blantyre). Over the 18 months study period
17.8% (63/353) of cases, 19% (74/377) of HC and 15.3% (58/
380) of CC were lost to follow-up, and the commonest reasons
being emigration out of the study area and withdrawal of consent.
There were no significant differences in baseline characteristics of
the children lost to follow-up compared to those that completed
the study follow-up period.
There were a few differences in the baseline characteristics of the
three groups (Table 1). Cases had a higher prevalence of stunting,
wasting and malaria compared to controls. It was found that iron
deficiency, determined in a subgroup of children only, was less
common in cases (46.4%, 96/207) than in HC (65.7%, 136/207,
p,0.001 ) or CC (73.1%, 152/208, p,0.001). Bacteraemia was
more common among cases (15.2%, 54/355) than HC (4.0%, 14/
353) with 72.1% (49/68) caused by non-typhoidal Salmonella.
Blood cultures were not done on CC. HIV prevalence was
significantly higher among the cases (12.7%, 45/553) than HC
(8.1%, 27/335, p=0.04) or CC (4.0%, 14/347, p,0.001).
Incidence of death in study groups
The overall all cause mortality rate (in-hospital and post-
discharge) was significantly higher among the cases, 17.2% (65/
377), than the combined control groups 2.0% (15/757, p,0.001,
Table 2). The incidence of death among cases was 0.148 per child-
year (95% CI 0.116–0.189) and they were ten times more likely to
die than controls (HR 9.5, 95% CI 5.4–16.7). Of these deaths
among the cases, 36.9% (24/65) occurred in hospital (mean
hospital stay in days=4.165.0SD) while the remaining 63.1%
(41/65) occurred during the post-discharge18 month follow-up
period. Most post-discharge deaths occurred in the community
and hence their cause could not be exactly determined, however
most deaths followed after a short history of illness. There were no
deaths that could have been remotely related to anaemia e.g.
trauma. The Kaplan-Meier plot (using censored data) of the three
cohorts of children (Figure 1) shows a significantly lower
proportion of cases than HC or CC surviving until the end of the
follow-up period. The post-discharge all cause mortality among
the cases was 12.6% compared to 2.9% and 1.4% in the HC and
CC groups respectively (Log rank test, p,0.001). Crude post-
discharge death rates not using censored data are presented in
Table 2. Post-discharge deaths among cases occurred after a
median time of 4.1 months (IQR 1.8–8.1), with 70.7% (29)
occurring within the first six months.
Risk factors for death in children treated for severe
anaemia (cases)
Nearly half the children who died, 45% (27/60) were infected
with HIV (Table 3). Among all study groups of children, HIV
infection was associated with an increased risk of dying (cases HR
9.4, 95% CI 5.0–17.5;H CHR 12.7, 95% CI 3.2–50.8;C CHR
17.1, 95% CI 2.9–102.2).
Table 1. Baseline characteristics by study group.
Baseline characteristics Cases Hospital Controls Community Controls
Urban site 202/377 (53.6%) 201/377 (53.3%) 203/380 (53.4%)
Age (in months)
1 20.4 (12.8) 22.5 (12.1) 25.3 (13.1)
Male 175/377 (46.4%) 197/377 (52.3%) 189/380 (49.7%)
History of previous transfusion 57/376 (15.2%) 22/376 (5.9%) 16/380 (4.2%)
Educated mother 321/364 (88.2%) 258/377 (68.4%) 296/376 (78.7%)
Wasting (z-score #2) 52/328 (15.9%) 28/339 (8.3%) 15/356 (4.2%)
Stunting (z-score #2) 175/329 (53.2%) 125/340 (36.8%) 162/357 (45.4%)
[Hb]
2 (g/dl)
1 3.6 (0.8) 9.6 (2.2) 9.9 (1.9)
Iron deficiency 96/207 (46.4%) 136/207 (65.7%) 152/208 (73.1%)
Malaria 222/376 (59.0%) 154/376 (41.0%) 167/374 (44.7%)
HIV 45/353 (12.7%) 27/335 (8.1%) 14/347 (4.0%)
Bacteraemia
3 54/355 (15.2%) 14/353 (4.0%) –
1mean (sd);
2Haemoglobin;
3blood cultures were not done on community controls
doi:10.1371/journal.pone.0002903.t001
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presented in Figure 2 and Table 4. Children who died were more
commonly HIV-infected than survivors and after adjusting for
confounders, HIV was strongly associated with death in the follow-
up period (HR 10.5, 95% CI 4.0–27.2). Overall all cause mortality
was 60.0% (27/45) among HIV infected and 10.7% (33/308)
among HIV uninfected severely anaemic children (p,0.001).
Bacteraemia was associated with a non-significantly increased risk
of post-discharge all cause mortality (HR 2.2, 95% CI 0.8–5.6).
Malaria, study site, sickle cell disease, G6PD or hookworm
infection did not significantly predict post-discharge death. Each
unit increase in age (in months) was associated with HR 0.92 (95%
CI 0.87–0.97, p=0.001).
Incidence of severe anaemia in study groups
Recurrence of first episode of severe anaemia was observed in
10.2% (Kaplan-Meier estimates) of cases during the 18-month
follow-up period, with a median time to event of 2.9 months (IQR
1.4–6.6) (Figure 3). Cases had a significantly higher rate of severe
anaemic episodes (Log rank test, p,0.001) during the follow-up
period than HC (1.1%) or CC (0.6%). Crude estimates of rates of
recurrence of first episode of severe anaemia are presented in
Table 2. All cause mortality and morbidity by study group.
Cases Hospital Controls Community Controls
Follow-up
Post-discharge follow-up (days)
2 537 (0–715) 540 (0–700) 540 (0–694)
Observation time (child-year) 440.1 506.1 535.0
Losses to follow-up at:
6 months 24/353 (6.8%) 23/377 (6.1%) 14/380 (3.7%)
12 months 36/353 (10.2%) 40/377 (10.6%) 26/380 (6.8%)
18 months 63/353 (17.8%) 74/377 (19.6%) 58/380 (15.3%)
Mortality
Total deaths 65 10 5
All cause mortality incidence
1 0.148 (0.116–0.189) 0.020 (0.011–0.037) 0.009 (0.003–0.022)
In-hospital mortality 24/377 (6.4%) 0/377 (0%) –
Total deaths post-discharge 41 10 5
Crude post-discharge mortality
3 at:
6 months 29/353 (8.2%) 6/377 (1.6%) 0/380 (0%)
12 months 36/353 (10.2%) 8/377 (2.1%) 2/380 (0.5%)
18 months 41/353 (11.6%) 10/377 (2.7%) 5/380 (1.3%)
Severe anaemia post-discharge
4
Number of children (episodes) 32 (42) 4 (5) 2 (2)
Incidence of severe anaemia
1,5 0.102 (0.075–0.138) 0.010 (0.004–0.024) 0.004 (0.001–0.016)
One or more episodes
6 at:
6 months 21/353 (5.9%) 2/377 (0.5%) 1/380 (0.3%)
12 months 29/353 (8.2%) 4/377 (1.1%) 2/380 (0.5%)
18 months 32/353 (9.1%) 4/377 (1.1%) 2/380 (0.5%)
Other morbidity
Number of sick-clinic visits
7 910 1185 791
Malaria positive
8 sick-clinic visits 384/871 (44.1%) 382/1131 (33.8%) 339/761 (44.5%)
Re-admissions to hospital
9 64/373 (17.2%) 35/371 (9.4%) 34/341 (10.0%)
Frequency of re-admissions:
None 309 337 341
1 time 45 29 32
2 times 14 4 2
3 times 5 2 0
1per child-year (95% Confidence Interval);
2median (range);
3assuming that all children loss to follow-up survived;
4all severe anaemia episodes were admitted to hospital and transfused;
5incidence based on number of episodes of severe anaemia;
6assuming that all children lost to follow-up did not have a severe anaemia episode;
7presented to study clinic due to illness;
8any asexual parasites/mL blood;
9number of children with at least one re-admission to hospital
doi:10.1371/journal.pone.0002903.t002
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children (cases) and hospital and community controls during the follow-up period.
doi:10.1371/journal.pone.0002903.g001
Table 3. Baseline characteristics of severe anaemia cases by outcome.
All deaths (n= 65) Post-discharge mortality (n= 41) Survivors (n= 312)
Urban site 41/65 (63.1%) 25/41 (61.0 %) 161/312 (51.6%)
Age (in months)
1 19.6 (12.5) 17.8 (10.8) 20.5 (12.8)
Male 25/65 (38.5%) 19/41 (46.3%) 150/312 (48.1%)
History of previous transfusion 9/64 (14.1%) 5/41 (12.2%) 48/312 (15.4%)
Educated mother 50/58 (86.2%) 31/38 (81.6%) 271/306 (88.6%)
Wasting 15/51 (29.4%) 7/35 (20.0%) 37/277 (13.4%)
Stunting 32/51 (62.7%) 23/35 (65.7%) 143/278 (51.4%)
Splenomegaly 37/63 (58.7%) 20/40 (50.0%) 198/307 (64.5%)
Hb (g/dl)
1 3.4 (0.8) 3.5 (0.6) 3.6 (0.9)
Iron deficiency 16/32 (50.0%) 13/25 (52.0%) 80/175 (45.7%)
Malaria 30/64 (46.9%) 22/41 (53.7%) 192/312 (61.5%)
HIV 27/60 (45.0%) 20/41 (48.8%) 18/293 (5.8%)
3
Bacteraemia 18/57 (31.6%) 12/41 (29.3%) 36/298 (12.1%)
1mean (SD);
3p,0.0001 between Survivors and All deaths or post-discharge mortality
doi:10.1371/journal.pone.0002903.t003
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occurring within the first six months after discharge from hospital.
The incidence of severe anaemia in the follow-up period among
the cases was 0.102 per person-year (95% CI 0.075–0.138)
compared to 0.007 per child-year (95% CI 0.003–0.015) for the
combined controls (p,0.0001). All children with an episode of
severe anaemia during the follow-up period were re-admitted to
hospital and given a blood transfusion.
Risk factors for recurrence of severe anaemia in children
treated for severe anaemia (cases)
Having more than 2 siblings, was strongly associated with an
increased risk of severe anaemia (AHR 5.0 95% CI 1.9–13.3)
(Table 5). From the history on admission, cases who had had a
previous transfusion or symptom of jaundice were more likely to
develop severe anaemia during the follow-up period (AHR 2.9,
95% CI 1.0–8.9; and AHR 11.8 95% CI 3.9–36.0 respectively).
Malaria on admission was associated with a protective effect, with
malaria affected cases having an 80% reduced risk of recurrence of
severe anaemia (AHR 0.2, 95% CI 0.1–0.7). HIV infection was
associated with a five times increased risk of recurrent severe
anaemia (AHR 5.6, 95% CI 1.6–20.1) among cases. Overall,
among all study groups of children, univariate analysis showed
that HIV infection was non-significantly associated with severe
anaemia (cases HR 1.9, 95% CI 0.7–5.0;H CHR 4.2, 95% CI 0.4–
40.6;C C -too few events to compute HR).
Other morbidity during the follow-up period
There were 910, 1185 and 791 sick-clinic visits for cases HC and
CC respectively (Table 2). Of these visits, there was a significantly
reduced proportion of malaria positive sick-visits among the HC
than cases or CC. (382/1131 HC vs. 384/871 cases, p=0.002; HC
Figure 2. Unadjusted (in black) and adjusted (in red) Hazard Ratios of main risk factors for post-discharge all cause mortality
among severely anaemic children (cases).
doi:10.1371/journal.pone.0002903.g002
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proportion of cases were re-admitted to hospital (64/373, 17.2%) as
compared to HC (35/371, 9.4%, p=0.007) and CC (34/341,
10.0%, p=0.01). These proportions were not significantly
different between the HC and CC (p=0.8).
Discussion
The in-hospital case-fatality rate of 6.4% in the present study is
within the range of previously reported studies in Sub-Saharan
Africa [2,3,17]. In-hospital deaths usually occur shortly after
Table 4. Risk factors for post-discharge all cause mortality among cases.
Factor
No. of
children
1 Univariate HR
2 (95% CI
3) p-value Adjusted HR (95% CI)
4 p-value
Age (in months)
Unit increase in age
5 345 0.98 (0.95–1.01) 0.2 0.92 (0.87–0.97) 0.001
Residency
Rural 175 1.72 (0.90–3.23) 0.10 1.63 (0.63–4.20) 0.31
Urban 202 1.00
Sex
Male 175 1.09 (0.58–2.02) 0.80 1.54 (0.68–3.52) 0.31
Female 202 1.00
Mother education
Some 321 1.63 (0.72–3.70) 0.25 NA
6
none 43 1.00
Parents employment
Unemployed 214 0.51 (0.26–1.04) 0.06 4.15 (1.61–10.74) 0.003
Employed 158 1.00
Wasting
,22 Z-score WH
7 52 0.74 (0.31–1.80) 0.51 NA
$22 Z score WH 276 1.00
Stunting
,22 Z-score HA
8 175 0.61 (0.30–1.22) 0.16 NA
$22 Z score HA 154 1.00
Splenomegaly
Present 235 1.73 (0.92–3.23) 0.09 0.36 (0.16–0.80) 0.01
Absent 135 1.00
Iron deficiency
$5.6 sTfR/Log ferritin 96 0.91 (0.41–2.03) 0.82 NA
,5.6 sTfR/Log ferritin 111 1.00
Malaria
Any parasite/mL blood 222 1.25 (0.67–2.34) 0.48 NA
0 parasite/mL blood 154 1.00
HIV
Positive 45 9.39 (5.05–17.49) ,0.0001 10.49 (4.05–27.20) ,0.0001
Negative 308 1.00
Bacteraemia
Present 54 3.85 (2.00–7.14) 0.001 2.17 (0.84–5.64) 0.11
Absent 301 1.00
1number of children included in Univariate model;
2Hazard Ratio;
3Confidence Interval;
4number of children included in the multivariable Cox Proportional Hazards model was 272. All variables with a univariate HR p-value #0.1 and important confounders
(age, sex, residency, HIV) were included in the multivariable model. Other factors not presented in the table that were included in the model were history of a previous
transfusion, Hb at admission;
5age was entered as a continuous variable in the model;
6not applicable;
7weight-for-height;
8height-for-age
doi:10.1371/journal.pone.0002903.t004
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important predictor of a fatal outcome [3]. Earlier identification of
these children in the community and more timely transfusion may
decrease these early deaths.
Of serious concern is the high post-discharge all cause mortality
observed among the cases in this study, most deaths occurring
within six months after admission for severe anaemia. The all
cause mortality rate over the same period was significantly lower in
other children attending the hospital (hospital controls) and in
children in the community (community controls). Children with
severe anaemia, even if treated in hospital, remain a highly
vulnerable group after discharge. Outside of the context of a
research study, such deaths may remain undetected by the health
services, and if recorded, the link with a previous episode of severe
anaemia may be unrecognized.
Before this study the longest follow-up of children after an
episode of severe anaemia was eight weeks, in an investigation in
rural Kenya [2]. Even in that relatively short period, the post-
discharge all cause mortality rate was found to be 14%, which the
investigators attributed to suboptimal medical care during
admission to hospital (poor disease recognition and inadequate
treatment). The present study has been the first attempt to validate
these Kenyan findings in a different setting and with an extended
follow-up period. We provided a good level of supervised medical
care during the initial admission, and were therefore surprised to
find that both post-discharge all cause mortality and the rate of
recurrence of severe anaemia, although better than in Kenya,
remained high.
Several possible explanations for the high incidence of post-
discharge all cause mortality and recurrent severe anaemia should
be considered. Firstly, it is possible that the underlying cause of the
initial episode of severe anaemia was neither diagnosed nor
treated, and therefore haemoglobin levels may have deteriorated
again after discharge. Considering the extensive diagnostic
investigations [6] and frequent follow-up visits that were carried
out by dedicated medical staff, this explanation appears unlikely.
Secondly, the aetiology of the severe anaemia episode may have
been identified correctly, but treatment failure occurred as a result
of multi-drug resistant malaria or bacterial infections. It has been
shown that recrudescent and new malaria infections during the
first six months can negate the initial haematological improvement
attained from receiving blood transfusion [2]. Children with
malaria in this study were treated with a combination of quinine
for at least three days and sulfadoxine-pyrimethamine according to
national policy. Although generally efficacious, this regimen is
known to have an increasing failure rate in formal studies in
Figure 3. Survival curve showing the time to first severe anaemia episode and the events versus number at risk of severely anaemic
children (cases) and hospital and community controls during the follow-up period.
doi:10.1371/journal.pone.0002903.g003
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recurrent anaemia in some children. However if failed malaria
treatment had been an important explanation of recurrent
anaemia, we might have expected recurrence to occur more
frequently among cases who had malaria parasitaemia at the time
of admission; in fact these children proved to have a lower
incidence of recurrent anaemia than those without malaria.
Thirdly, cases may have been seen in the end-stage of a chronic
underlying disease, with severe anaemia being merely a marker of
disease severity. This hypothesis is supported by the fact that HIV
infection was found to be the most important independent risk
factor for post-discharge all cause mortality. Anaemia is not only a
common paediatric manifestation of HIV, but has been shown to
be strongly and consistently associated with the progression of
HIV disease and death [18,19]. At the time of this study, anti-
retroviral therapy (ART) was not available to children in Malawi.
Currently ‘unexplained moderate anaemia’ is a stage III criterion–
i.e. a provisional indication–for commencing ART, but in practice
this is often not used in deciding which children should be started
on ART. Our finding of a very high HIV-related case fatality rate
in severely anaemic children suggests that it is now appropriate to
consider adding severe anaemia to the criteria for stage IV
disease–ie a definite indication for commencing ART–in the
WHO paediatric HIV staging system.
Finally, inadequate blood transfusion may explain the high rates
of post-discharge all cause mortality and recurrent severe anaemia,
Table 5. Risk factors for recurrence of severe anaemia among cases.
Factor No. of children
1 Univariate HR
2 (95% CI
3) p-value Adjusted HR (95% CI)
4 p-value
Age (in months)
Unit increase in age
5 340 1.00 (0.97–1.03) 0.9 0.97 (0.94–1.00) 0.08
Residency
Rural 175 0.76 (0.38–1.52) 0.44 0.63 (0.25–1.60) 0.33
Urban 202 1.00
Sex
Male 175 0.57 (0.27–1.17) 0.13 0.61 (0.23–1.61) 0.31
Female 202 1.00
No. of siblings
.2 171 2.09 (1.00–4.37) 0.05 4.98 (1.87–13.25) 0.001
#2 204 1.00
History of previous transfusion
Yes 57 1.65 (0.71–3.81) 0.24 NA
6
No 319 1.00
History of jaundice
Yes 22 4.23 (1.74–10.32) 0.002 11.84 (3.90–35.96) ,0.0001
No 350 1.00
Splenomegaly
Present 235 0.41 (0.21–0.83) 0.01 0.98 (0.38–2.51) 0.98
Absent 135 1.00
Iron deficiency
$5.6 sTfR/Log ferritin 96 0.98 (0.40–2.42) 0.97 NA
,5.6 sTfR/Log ferritin 111 1.00
Malaria
Any parasite/mL blood 222 0.38 (0.18–0.77) 0.007 0.24 (0.09–0.65) 0.005
0 parasite/mL blood 154 1.00
HIV
Positive 45 1.91 (0.73–4.99) 0.19 5.63 (1.58–20.07) 0.008
Negative 308 1.00
Bacteraemia
Present 54 1.05 (0.37–3.00) 0.93 NA
Absent 301 1.00
1number of children included in Univariate model;
2Hazard Ratio;
3Confidence Interval;
4number of children included in the multivariable Cox Proportional Hazards model was 307. All variables with a univariate HR p-value #0.1 and important confounders
(age, sex, residency, HIV) were included in the multivariable model. The other factor not presented in the table but included in the model was undernutrition;
5age was entered as a continuous variable in the model;
6not applicable
doi:10.1371/journal.pone.0002903.t005
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tried to prevent this happening by evaluating haemoglobin levels
after transfusion and before discharge, and repeating transfusions
if necessary. Nevertheless, in cases haemoglobin concentrations
were still well below the normal range following transfusion–a
situation that is likely to prevail in many health facilities in Africa–
and a relatively minor additional haematological insult could have
major consequences.
Iron status determination in populations were inflammatory
conditions are common can be challenging. In this study sTfR-Log
ferritin index was used after assessment with bone marrow iron
aspirates found it to best predict bone marrow iron status [10].
However, other studies where sTfR and ferritin were assessed
separately, these iron status markers showed large alterations with
inflammation [20,21,22]. Although iron deficiency was not
associated with an increased risk of post-discharge all cause
mortality, it was less prevalent among the cases on admission than
among controls. This observation supports the hypothesis that iron
deficiency may provide an unfavourable environment for bacterial
growth [23]. It is also in agreement with observations of increased
morbidity and mortality during iron-supplementation studies in
areas where bacterial infections are common [24]. However the
effect of iron supplementation in this present study could not be
properly determined.
The importance of bacteraemia has been shown in a previous
study in Malawi, where it was associated with severe anaemia [25].
Non-typhoidal salmonellae, principally S. typhimurium and S.
enteritidis, are widely prevalent in Africa and are associated with
malaria and HIV infection [26]. In our study bacteraemia was
more common among cases than HC, though a comparison with
CC could not be made. This association may be due in part to the
higher prevalence of malaria and HIV infection in cases than
controls, malaria and HIV being known risk factors for
bacteraemia. Bacteraemia was not an independent risk factor for
post discharge all cause mortality or recurrence of severe anaemia.
Whether routine treatment with antibiotics should be given to all
children with severe anaemia remains a matter of debate. Our
data suggest that this would be a reasonable policy where blood
cultures cannot be carried out.
Our analysis included only risk factors that could be ascertained
at the time of admission. Causes of a post-discharge death, if it
occurred in the community, could only be investigated retrospec-
tively by using the verbal autopsy method. Verbal autopsies are
known to be neither very sensitive nor specific; therefore the true
causes of post-discharge all cause mortality in the study population
could not be clearly determined [27]. A limitation to the study was
that it was carried out during the time when ART was not freely
available to children. The impact of HIV infection on post-
discharge all cause mortality in severely anaemic children is likely
to be less in children to whom ART is available.
This study provides disturbing evidence of consequences of
severe anaemia on child health and survival. It is commonly
thought that most deaths due to severe anaemia occur in hospital
[3]. This study shows that there is an even greater mortality post-
discharge. This ‘hidden’ post-discharge all cause mortality,
calculated at 12.6% during 18 months (compared to 2% in the
combined controls), is likely to be an underestimate, as it is based
on the assumption that all children lost to follow-up survived. We
have also shown that severe anaemia is followed by an increased
risk of further episodes of severe anaemia. In this study, HIV
infection proved to be the most important risk factor both for
recurrent anaemia and for death during the follow-up period. As
severe anaemia is very common [2], the impact on overall under-
five morbidity and mortality is likely to be considerable. Increased
attention to the prevention and management of underlying
diseases causing severe anaemia in African children is urgently
needed if the fourth millennium development goal (MDG4)–a
significant reduction in child mortality–is to be achieved.
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